N onalcoholic fatty liver disease (NAFLD) has emerged as a growing health problem affecting up to one third of the population worldwide, and its incidence is increasing rapidly because of the epidemics of obesity and type 2 diabetes mellitus (T2DM). 1 The NAFLD is a spectrum of chronic liver diseases ranging from simple fatty liver to nonalcoholic steatohepatitis, which can progress to cirrhosis and liver failure. The prevalence of NAFLD in subjects with the metabolic syndrome (MetS) is increased 4-fold when compared with those without the disease and ≥30% of NAFLD subjects have MetS. 2 Each of the key components of the MetS, insulin resistance in particular, associates strongly with NAFLD. 3 Emerging evidence suggests that NAFLD may be a cardiovascular disease risk factor. 1 Whether NAFLD is only a surrogate marker of multiple risk factors clustering in the MetS is still debated.
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Recently, ectopic fat depots have been classified into 2 subtypes according to either their systemic or local effects. 4 Proton magnetic resonance spectroscopy ( 1 H-MRS) has revealed that triglyceride increase also in cardiomyocytes can be a marker of cardiac function. 5, 6 Early subclinical left ventricular (LV) diastolic dysfunction, as measured by tissue Doppler echocardiography, has been shown to associate with NAFLD in nondiabetic 7 and in T2DM 8 subjects. To date, few MRS studies have been published on cardiac function in NAFLD, and the results are controversial. Hepatic fat content and myocardial insulin resistance have been found to be associated in T2DM men, but LV function and morphology were not studied. 9 Rijzewijk et al 10 showed, in men with uncomplicated T2DM, that patients with increased intrahepatic fat content had reduced myocardial perfusion and lower myocardial phosphocreatinine (PCr)/ATP ratio but similar LV function and morphology. Similarly, Perseghin et al 11 demonstrated that nondiabetic men with increased intrahepatic fat content had impaired LV energy metabolism when compared with controls, despite normal LV morphology and function. Conversely, Hallsworth et al 12 did not find any significant differences in PCr/ATP ratio, Background-Nonalcoholic fatty liver disease has emerged as a novel cardiovascular risk factor. The aim of the study was to assess the effect of different ectopic fat depots on left ventricular (LV) function in subjects with nonalcoholic fatty liver disease. Methods and Results-Myocardial and hepatic triglyceride contents were measured with 1.5 T magnetic resonance spectroscopy and LV function, visceral adipose tissue (VAT) and subcutaneous adipose tissue, epicardial and pericardial fat by MRI in 75 nondiabetic men. Subjects were stratified by hepatic triglyceride content into low, moderate, and high liver fat groups. Myocardial triglyceride, epicardial and pericardial fat, VAT, and subcutaneous adipose tissue increased stepwise from low to high liver fat group. Parameters of LV diastolic function showed a stepwise decrease over tertiles of liver fat and VAT, and they were inversely correlated with hepatic triglyceride, VAT, and VAT/subcutaneous adipose tissue ratio. In multivariable analyses, hepatic triglyceride and VAT were independent predictors of LV diastolic function, whereas myocardial triglyceride was not associated with measures of diastolic function. Conclusions-Myocardial triglyceride, epicardial and pericardial fat increased with increasing amount of liver fat and VAT. Hepatic steatosis and VAT associated with significant changes in LV structure and function. The association of LV diastolic function with hepatic triglyceride and VAT may be because of toxic systemic effects. The effects of myocardial triglyceride on LV structure and function seem to be more complex than previously thought and merit further study. and the LV diastolic function parameters were similar in the NAFLD and control groups. This study was set up to examine, in a cohort of nondiabetic men free of cardiovascular disease, the effect different ectopic fat depots on LV structure and function in subjects with NAFLD.
Methods

Study Design
A total of 75 men were included in the study. The study recruitment has been published previously. 13 To explore the role of liver fat, the subjects were categorized into tertiles based on hepatic triglyceride content: group 1 (n=24): hepatic triglyceride low; group 2 (n=26): hepatic triglyceride moderate; and group 3 (n=25): hepatic triglyceride high. Thirty-seven participants fulfilled the criteria for the MetS.
14 In these participants, myocardial ischemia was excluded by means of adenosine stress perfusion MR. Exclusion criteria included known acute or chronic disease based on history, physical examination, and standard laboratory tests (blood counts, creatinine, aspartate aminotransferase, alanine aminotransferase, and thyroid-stimulating hormone), T2DM (based on a 2-hour oral glucose tolerance test), significant alcohol consumption defined as >20 g/d, and treatment with antidiabetic drugs and lipid-lowering therapy, except for statins. Only men were included because the hormonal status or the use of contraceptives modify lipid metabolism in women. Elevated liver enzymes were allowed ≤4-time upper limit of normal (70 U/L). Five subjects, 2 in the group with moderate liver fat and 3 in the high liver fat group, received medications for hypertension, 3 subjects in the high liver fat group for dyslipidemia (statins), and 1 in the high liver fat group for both hypertension and dyslipidemia. The antihypertensive medications were angiotensin-converting enzyme inhibitors (n=2), angiotensin II type 1 receptor blockers (n=3), or calcium-channel blockers (n=1). Written informed consent was obtained from all participants, and the study design was approved by the institutional ethics committee.
Demographic Variables and Biochemical Investigations
Body mass index was calculated by dividing weight in kilograms by height in meters squared (kg/m 2 ). Waist circumference was determined midway between iliac crest and the lower rib margin. Blood pressure was measured by BPM-200 (Quick Medical, Issaquah, WA) in the sitting position after a 5-minute rest, and the mean of 5 measurements was recorded. The subjects were classified as present, past, or nonsmokers.
Blood samples were collected after overnight fasting. Total serum cholesterol, triglycerides, high-density lipoprotein cholesterol, free fatty acids, and apolipoprotein B were automatically analyzed by Konelab analyzer 60i (Thermo Fisher Scientific Oy, Vantaa, Finland) with Konelab TM kits. The concentration of low-density lipoprotein cholesterol was calculated using the Friedewald formula. 15 Measurement of aspartate aminotransferase, alanine aminotransferase, creatinine, and thyroid-stimulating hormone was performed using standard laboratory techniques. Fasting and postload glucose were determined by the hexokinase method (Roche Diagnostic Gluco-quant) using either a Hitachi 917 or a Modular analyzer (Hitachi Ltd, Tokyo, Japan). Serum insulin concentration was assessed by double-antibody radioimmunoassay (Pharmacia RIA kit; Pharmacia, Uppsala, Sweden). The insulin-resistance homeostasis model assessment index was calculated using the following formula: (fasting plasma glucose×fasting plasma insulin)/22.5.
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LV Analysis and Determination of Abdominal Fat Volumes
Cardiac imaging was performed with a 1.5 Tesla whole-body MR imager (MAGNETOM Avanto; Siemens AG, Erlangen, Germany). A multichannel body coil was used for reception. Cine series were acquired in 4-chamber, 2-chamber, and LV short-axis orientations during breath hold using a retrospectively electrocardiographically gated steady state free precession gradient echo sequence. A stack of short-axis cine series (typically 12 slices) was acquired from base to apex covering the whole LV. Typical imaging parameters were repetition time/echo time/flip angle 50 ms/118 ms/69°, matrix 186×220, field of view 355×420 mm, slice thickness 8 mm, gap 2 mm, and temporal resolution 32 to 53 ms.
Volumetric analysis of the LV was scrutinized using dedicated postprocessing software (Argus, Siemens). LV ejection fraction, mass, end-diastolic, end-systolic, and stroke volumes were reported, and volume parameters and mass were indexed to subject's body surface area. LV early diastolic peak filling rate (PFR) was obtained from the LV volume versus time curve. LV end-diastolic volume normalized values of peak filling rate (PFR/LVEDV) were also reported. The LV filling curve was visually inspected to identify the plateau between the early diastolic phase caused by ventricular relaxation and the late diastolic phase caused by atrial contraction. The resulting diastolic plateau volume was divided by end-diastolic volume, and the resulting percentile was reported as the ratio of LV early diastole.
The distributions of visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) were determined as previously described. 17 We calculated the VAT/SAT ratio as a metric of abdominal fat distribution.
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Determination of Epicardial and Pericardial Fat
Four-chamber oriented cine images of the heart were used for the quantification of epicardial and pericardial fat, as described in detail previously, and show high intra-and interobserver reproducibility. 13, 17 After examination of all phases of the cine images, areas of fat layers between the myocardium and the visceral pericardium (epicardial fat) and the intrathoracic fat outside the parietal pericardium (pericardial fat) were measured in the enddiastolic image.
Determination of Myocardial and Hepatic Triglyceride Content
Myocardial and hepatic triglyceride contents were measured by 1 H-MRS with a 1.5 Tesla (MAGNETOM Avanto; Siemens AG) whole-body MR imager. For myocardial acquisition, a 36×24×10 mm 3 voxel was positioned in the interventricular septum wall. A PRESS technique with echo time of 35 ms was used for spatial localization and data acquisition from the myocardium was double triggered to account for both respiration and cardiac pulsation as previously described. 17 For determination of hepatic triglyceride content, a 25×25×25 mm 3 voxel was placed in the middle of the right liver lobe avoiding large vessels and intrahepatic bile ducts. A PRESS sequence with echo time of 30 ms and repetition time of 3000 ms was used for spatial localization. Four acquisitions without water suppression were collected during free breathing. Figure 1 shows cardiac and hepatic spectra from 2 subjects. Spectroscopic acquisition from the myocardium was double triggered to account for both respiration and cardiac pulsation.
Statistical Analyses
All statistical analyses were performed with SPSS 19.0 for Windows (SPSS, Inc, Chicago, IL). Data are presented as frequencies or percentages for categorical variables, as mean±SD for normally distributed continuous variables, and as medians (range) for skewed variables. Normality of continuous variables was analyzed by the Kolmogorov-Smirnov test. Logarithmic transformation of variables with skewed distribution was done before any statistical analyses. Between-group differences were examined by 1-way ANOVA, and P values for pairwise between groups difference were adjusted for multiple comparison in a post hoc Bonferroni t test. Categorical data were compared by the χ 2 test. ANCOVA was applied to compare the means or medians of LV dimensions and function with adjustment for age. Levene test was used to assess homogeneity of variances. If variances were not homogenous across the groups, the nonparametric Kruskal-Wallis test was used. Correlations were calculated 
Results
Clinical and biochemical characteristics of the study groups are summarized in Table 1 . Subjects with high liver fat were older, had higher body mass index, waist circumference, heart rate, systolic and diastolic blood pressures compared with the other groups. There were more current smokers in individuals with high liver fat when compared with those with low liver fat (10 [40%] versus 2 [8%]; P=0.018). Participants with high liver fat shared all features of the atherogenic dyslipidemia with hypertriglyceridemia, lower high-density lipoprotein cholesterol, higher low-density lipoprotein cholesterol and a high concentration of apolipoprotein B, as well as elevated glucose and insulin levels and insulin-resistance homeostasis model assessment, when compared with those with the low liver fat group. Free fatty acids were comparable among the groups (Table 1) . Myocardial triglyceride was 3-fold higher in the high liver fat group and 2-fold higher in the moderate liver fat group when compared with that in the low liver fat group. Similarly, epicardial and pericardial fat depots were increased in the high liver fat group when compared with those with the 2 other groups. As expected, VAT and SAT increased stepwise from the low to high liver fat group. The VAT/SAT ratio was comparable in the groups with moderate and high liver fat but significantly lower in the group with low liver fat (Table 1) .
In the age-adjusted analyses parameters of LV diastolic function showed a stepwise decrease over tertiles of liver fat (Table 2; Figure 2 ). The PFR, PFR/LVEDV, and ratio of LV early diastole differed significantly between the high and low liver fat groups. All parameters behaved similarly when the subjects were categorized based on VAT (Figure 2 ; Tables I and II in the Data Supplement). This was not unexpected because hepatic triglyceride and VAT were clearly correlated (r=0.832; P<0.001). No significant differences were found in the LV ejection fraction and LV mass and end-systolic volume indexed to body surface area in the groups with different liver fat content. Subjects with high liver fat had decreased LV end-diastolic and stroke volumes indexed to body surface area compared with patients with low liver fat.
In univariate correlation analyses, PFR and PPFR/LVEDV were inversely correlated with hepatic triglyceride and VAT. Furthermore, PFR was inversely correlated with the VAT/ SAT ratio. The ratio of LV early diastole was correlated only with pericardial fat. No significant correlations were found between indices of diastolic function and myocardial triglyceride content (Table 3) .
Multivariable regression analyses with diastolic function parameters as independent variables and different ectopic fat depots as dependent variables showed that hepatic triglyceride was an independent predictor of PFR and PFR/LVEDV (Table 4 , model 1). The results of multivariable analyses were closely similar when hepatic triglyceride was replaced with VAT (Table 4 , model 2). No significant association was found between myocardial triglyceride and diastolic parameters. Only pericardial fat was related to the ratio of LV early diastole (Table 4) .
Discussion
To the best of our knowledge, this is the first study using MR technology to examine, in a large cohort of nondiabetic men free of cardiovascular disease, the effects of different ectopic fat depots on the development of LV diastolic function. The main findings of the study are as follows: (1) myocardial triglyceride and epicardial and pericardial fat depots increased in a stepwise manner across the tertiles of hepatic triglyceride and VAT; (2) hepatic triglyceride and VAT correlated with the degree of LV diastolic function; and (3) myocardial triglyceride was not independently associated with measures of diastolic function.
Growing data suggest that cardiac steatosis comprises not only fat accumulation in epi-and pericardial spaces but also triglyceride accumulation in cardiomyocytes. 19 Our study showed that ectopic fat in all 3 cardiac sites accumulated in a stepwise pattern with increasing amount of both hepatic triglyceride and VAT. As expected, the subjects in the highest tertile of hepatic triglyceride also exhibited more SAT than subjects in the lowest tertile of hepatic triglyceride. In multivariable analyses, carefully adjusted for confounding factors, both hepatic triglyceride and VAT associated with diastolic parameters independently of SAT, emphasizing the synergistic role of these 2 subcategories of ectopic fat. The subjects in the highest tertile of hepatic triglyceride or VAT had decreased LV volumes indexed to body surface area compared with individuals in the lower tertiles of hepatic triglyceride. Our data are in agreement with data by Hallsworth et al, 12 who reported a small reduction in end-systolic and enddiastolic blood pool volumes in 19 adults with NAFLD. In contrast, Perseghin et al 11 reported that LV morphological features were similar between nondiabetic men with high when compared with those with low liver triglyceride content. Similarly, differences in LV systolic and diastolic dimensions were not observed in patients with T2DM and NAFLD. 10 Overall, our data evidence that LV diastolic function assessed by MRI was impaired in the high liver fat group when compared with that in the low liver fat group. No significant change in the LV systolic function was found between the groups, in agreement with previous studies. [10] [11] [12] The study design does not allow us to evaluate the molecular mechanisms underlying cardiac steatosis. The accumulation of intramyocardial triglyceride results from the imbalance of fatty acid uptake and oxidation in the heart. Heart and liver share the peculiar position of first-pass organs being exposed directly to free fatty acid flux from the visceral fat depots. Other potential sources for free fatty acids are lipolysis of circulating lipoproteins by lipoprotein lipase, hydrolysis of intramyocardial triglyceride by adipose triglyceride lipase, and uptake of lipids via very low-density lipoprotein receptors. [20] [21] [22] In this context, it is interesting that the expression of both sterol-regulatory element-binding protein-1c and peroxisome proliferator activated receptor-γ were reported to be increased in heart biopsies of subjects with the MetS, reflecting adaptation to metabolic derangements. 23 Recently, dynamic positron emission tomographic imaging of both heart and liver was used to follow-up the fate of dietary fatty acids in humans. 24 These elegant studies demonstrated that obese subjects with impaired glucose tolerance displayed both increased fatty acid uptake and oxidation of postprandial dietary fatty acids. Thus, the oversupply of fatty acids from dietary fat can also be a significant source for intramyocardial fat. Recently, the role of triglyceride catabolism in the heart has come up as an adaptive response to ameliorate the lipotoxicity in the heart. 25 Overall, Data are expressed as mean (±SD) or medians (range). ALT indicates alanine aminotransferase; fP, fasting plasma; fS, fasting serum; HOMA-IR, the homeostasis model assessment insulin resistance; SAT, subcutaneous fat; TG, triglyceride; and VAT, visceral adipose tissue.
P a values are presented for ANOVA between hepatic TG content groups. *Differs significantly (P<0.05) from hepatic TG content group low †Differs significantly (P<0.05) from hepatic TG content group moderate. Tests are Bonferroni adjusted for multiple comparisons. ‡ANOVA based on Kruskal-Wallis test. Ectopic Fat, Left Ventricular Function, and Fatty Liver intramyocardial triglyceride pool is less inert than epi-and pericardial fat compartments and seems to be more flexible and adaptive for changes in metabolic milieu.
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Data on the impact of intramyocardial triglyceride on LV function is limited and partly inconsistent. Echocardiographic measures of LV performance have demonstrated that patients with T2DM and elevated myocardial triglyceride display significant impairment of LV diastolic function. 26, 27 Likewise, a significant association between myocardial steatosis and impaired diastolic function has been shown by perfusion MR in T2DM. 5, 6 In this study, intramyocardial triglyceride was not a determinant of diastolic function in multivariable analyses, including hepatic triglyceride and VAT. Similarly, neither epi-nor pericardial fat depots correlated with the 2 parameters reflecting best the LV diastolic function. These data suggest that the associations of epi-and pericardial fat depots with impaired diastolic function are probably indirect and because of their close correlations with both hepatic and visceral fat depots. 13 In line, the largest study reported to date of patients with T2DM failed to demonstrate any relationship between the degree of myocardial triglyceride accumulation and diastolic function. 25 The results of our multivariable analyses suggest that visceral adiposity and hepatic triglyceride content lies at the root of the systemic toxic effects and LV Thus, both NAFLD and VAT seem to influence cardiovascular disease risk by both associating with metabolic risk and LV diastolic dysfunction.
Limitations
Both sex and age may influence the magnitude of cardiac steatosis and LV diastolic function although the data are not consistent. 19, 28 Accordingly, only men were included in this study, and the data were adjusted to age. Recently, the increase of myocardial triglyceride content was reported in insulin-resistant obese women also. 29 In addition, data from a large and community-based study have shown that there is a sex difference in the propensity to store fat viscerally versus subcutaneously. 18 In women, VAT/SAT ratio is to a larger extent determined by VAT than by SAT, than in men. 18 Cigarette exposure has been associated with ultrasound-defined NAFLD, 30 and fatty liver associates with smoking and with metabolic derangements. 31 In our study, there were more current smokers in the high liver fat group when compared with those with the low liver fat group. Smoking might be a confounder. However, our results remained significant after adjusting for smoking. Although the measurements of diastolic function consisted of multiple parameters, they were based on LV short-axis cine images. Other methods, such as transmitral velocity-encoded flow analysis, might have served as an internal reference. However, pseudonormal E/A-pattern related to diastolic dysfunction might be a pitfall of this technique. In our experience, velocity measurements are easily subject to averaging errors because of data gathering time of several minutes and intracycle variation. Finally, because the study design is cross-sectional and observational interferences of causality remain limited.
Conclusions
All 3 cardiac ectopic fat depots accumulate in a stepwise pattern with increasing amount of both hepatic triglyceride and VAT. Hepatic steatosis together with VAT associate with significant changes in LV structure and function. The association of LV diastolic function with hepatic triglyceride and VAT All models were adjusted for age, body mass index, waist circumference, blood pressure parameters, heart rate, smoking status, triglycerides, high-density lipoprotein cholesterol, and fasting plasma glucose. β indicates regression coefficient; LV, left ventricular; and TG, triglyceride.
